EGFR and lung cancer: As proof‐of‐concept of this type of molecular surgery for lung cancer, we propose to use CRISPR/Cas9 to repair or destroy the EGFR gene in EGFR‐mutant NSCLC, as shown in Fig 1, with examples from the most common primary and secondary mutations.